• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Treatment strategies for chronic total occlusion: current status and outlook].

作者信息

Werner G S

机构信息

Medizinische Klinik I, Klinikum Darmstadt, Deutschland.

出版信息

Herz. 2011 May;36(3):222-30. doi: 10.1007/s00059-011-3461-4.

DOI:10.1007/s00059-011-3461-4
PMID:21541737
Abstract

The present article discusses the current status of treatment strategies for chronic total occlusion (CTO) and the prospects offered by new therapies. The indication for revascularisation recognized in the current European guidelines includes the presence of typical symptoms and evidence of ischemia of over 10% of the total myocardium, while in patients with multiple vascular diseases the aim is complete revascularisation. Although the vast majority of patients with CTO fulfil these criteria, they are currently not receiving interventional treatment as frequently as expected. The reasons often given for this include the low success rates and high recurrence rates. However, both problems have been improved by drug-eluting stents (DES) on the one hand and by wire techniques and strategies on the other, such that results almost comparable with non-occluded coronary lesions can be achieved. While more advanced approaches like retrograde recanalization should be restricted to specialized centres, marked improvements can be achieved even without these special techniques by means of consistent further training and the application of modern techniques. Despite the aggressiveness of these approaches to pass through an occluded artery, the complication rate is not higher than with non-occluded lesions when the specific complications of recanalization are avoided in a careful approach. Further technical improvements are expected with the use of modern imaging techniques such as intravascular ultrasound and high-resolution CT imaging of coronary arteries.

摘要

相似文献

1
[Treatment strategies for chronic total occlusion: current status and outlook].
Herz. 2011 May;36(3):222-30. doi: 10.1007/s00059-011-3461-4.
2
[Chronic coronary occlusions : When and how should revascularization be performed?].[慢性冠状动脉闭塞:何时以及应如何进行血运重建?]
Herz. 2016 Nov;41(7):585-590. doi: 10.1007/s00059-016-4464-y.
3
4
Incidence, predictors, and outcomes of distal vessel expansion on follow-up intravascular ultrasound after recanalization of chronic total occlusions using new-generation drug-eluting stents: Data from the CTO-IVUS randomized trial.使用新一代药物洗脱支架对慢性完全闭塞病变进行再通后,随访血管内超声检查时远端血管扩张的发生率、预测因素及结果:来自CTO-IVUS随机试验的数据
Catheter Cardiovasc Interv. 2020 Jan;95(1):154-164. doi: 10.1002/ccd.28461. Epub 2019 Aug 28.
5
Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002.慢性完全闭塞病变的经皮冠状动脉介入治疗:胸科中心1992 - 2002年经验
Eur Heart J. 2005 Dec;26(24):2630-6. doi: 10.1093/eurheartj/ehi498. Epub 2005 Sep 23.
6
Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization: Results From the EXPERT CTO Multicenter Trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions).依维莫司洗脱支架在慢性完全闭塞血运重建中的安全性和有效性:来自 EXPERT CTO 多中心试验(依维莫司药物洗脱冠状动脉支架在慢性完全闭塞病变中的应用、表现和技术评估)的结果。
JACC Cardiovasc Interv. 2015 May;8(6):761-769. doi: 10.1016/j.jcin.2014.12.238. Epub 2015 Apr 22.
7
Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.下肢外周动脉疾病的支架置入术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(18):1-88. Epub 2010 Sep 1.
8
Chronic total coronary occlusion recanalization: Current techniques and new devices.慢性完全性冠状动脉闭塞再通:当前技术与新设备
J Saudi Heart Assoc. 2017 Apr;29(2):110-115. doi: 10.1016/j.jsha.2016.08.003. Epub 2016 Aug 20.
9
Late (3 years) follow-up of successful versus unsuccessful revascularization in chronic total coronary occlusions treated by drug eluting stent.药物洗脱支架治疗慢性完全闭塞性冠状动脉病变血运重建成功与失败的 3 年随访结果。
Am J Cardiol. 2012 Oct 1;110(7):948-53. doi: 10.1016/j.amjcard.2012.05.025. Epub 2012 Jun 19.
10
Chronic total coronary occlusion in patients with intermediate viability: value of low-dose dobutamine and contrast-enhanced 3-T MRI in predicting functional recovery in patients undergoing percutaneous revascularisation with drug-eluting stent.中等存活心肌患者的慢性冠状动脉完全闭塞:低剂量多巴酚丁胺和对比增强3-T磁共振成像在预测接受药物洗脱支架经皮血管重建术患者功能恢复中的价值
Radiol Med. 2009 Aug;114(5):692-704. doi: 10.1007/s11547-009-0426-2. Epub 2009 Jun 23.

引用本文的文献

1
A comparison of procedural success rate and long-term clinical outcomes between in-stent restenosis chronic total occlusion and de novo chronic total occlusion using multicenter registry data.多中心注册研究数据比较支架内再狭窄慢性完全闭塞和初发慢性完全闭塞患者的介入治疗成功率和长期临床结局。
Clin Res Cardiol. 2020 May;109(5):628-637. doi: 10.1007/s00392-019-01550-7. Epub 2019 Sep 24.
2
Chronic total coronary occlusion recanalization: Current techniques and new devices.慢性完全性冠状动脉闭塞再通:当前技术与新设备
J Saudi Heart Assoc. 2017 Apr;29(2):110-115. doi: 10.1016/j.jsha.2016.08.003. Epub 2016 Aug 20.

本文引用的文献

1
The BridgePoint devices to facilitate recanalization of chronic total coronary occlusions through controlled subintimal reentry.通过控制内膜下再进入,BridgePoint 设备有助于实现慢性全冠状动脉闭塞的再通。
Expert Rev Med Devices. 2011 Jan;8(1):23-9. doi: 10.1586/erd.10.76.
2
The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.对比剂容积与肾小球滤过率的比值可预测 ST 段抬高型急性心肌梗死经皮冠状动脉介入治疗的结局。
Catheter Cardiovasc Interv. 2011 Aug 1;78(2):198-201. doi: 10.1002/ccd.22828. Epub 2010 Oct 14.
3
Contemporary success and complication rates of percutaneous coronary intervention for chronic total coronary occlusions: results from the ALKK quality control registry of 2006.
2006 年德国心脏中心冠状动脉慢性完全闭塞病变介入治疗的当代成功率和并发症发生率:ALKK 质量控制注册研究结果。
EuroIntervention. 2010 Aug;6(3):361-6. doi: 10.4244/EIJV6I3A60.
4
Short and long term comparison (24 months) of an alternative sirolimus-coated stent with bioabsorbable polymer and a bare metal stent of similar design in chronic coronary occlusions: the CORACTO trial.短期和长期对比(24 个月):一种新型西罗莫司涂层、带生物可吸收聚合物的支架与设计相似的金属裸支架在慢性冠状动脉闭塞中的应用:CORACTO 试验。
EuroIntervention. 2010 Aug;6(3):356-60. doi: 10.4244/EIJV6I3A59.
5
Guidelines on myocardial revascularization.心肌血运重建指南。
Eur Heart J. 2010 Oct;31(20):2501-55. doi: 10.1093/eurheartj/ehq277. Epub 2010 Aug 29.
6
Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis.慢性完全闭塞再通的有效性:系统评价和荟萃分析。
Am Heart J. 2010 Jul;160(1):179-87. doi: 10.1016/j.ahj.2010.04.015.
7
Comparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: results of the GISSOC II-GISE multicentre randomized trial.比较西罗莫司洗脱支架和裸金属支架治疗完全闭塞性冠状动脉病变患者的疗效:GISSOC II-GISE 多中心随机试验结果。
Eur Heart J. 2010 Aug;31(16):2014-20. doi: 10.1093/eurheartj/ehq199. Epub 2010 Jun 20.
8
Highlights and essentials from the first "Experts-live" course of the EuroCTO club.欧洲慢性完全闭塞病变俱乐部首个“专家在线”课程的重点与要点。
EuroIntervention. 2010 Apr;5(8):888-90.
9
Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis.药物洗脱支架治疗慢性完全闭塞性冠状动脉再通的疗效和安全性:系统评价和荟萃分析。
J Am Coll Cardiol. 2010 Apr 27;55(17):1854-66. doi: 10.1016/j.jacc.2009.12.038.
10
European perspective in the recanalisation of Chronic Total Occlusions (CTO): consensus document from the EuroCTO Club.欧洲慢性完全闭塞病变(CTO)再通的观点:欧洲CTO俱乐部共识文件
EuroIntervention. 2007 May;3(1):30-43.